Bacitracin: Difference between revisions
Gerald Chi (talk | contribs) m Changed protection level for "Bacitracin" ([Edit=Allow only autoconfirmed users] (expires 13:51, 21 January 2014 (UTC)) [Move=Allow only autoconfirmed users] (expires 13:51, 21 January 2014 (UTC))) |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | |||
{{Bacitracin}} | |||
{{CMG}}; {{AE}} {{MM}} | |||
}} | |||
{{ | |||
{{ | |||
==Overview== | ==Overview== | ||
Line 28: | Line 8: | ||
Bacitracin is synthesised via the so-called nonribosomal peptide synthetases (NRPSs), which means that [[ribosome]]s are not involved in its [[nonribosomal peptide|synthesis]]. | Bacitracin is synthesised via the so-called nonribosomal peptide synthetases (NRPSs), which means that [[ribosome]]s are not involved in its [[nonribosomal peptide|synthesis]]. | ||
== | ==Category== | ||
[[beta-lactam antibiotic]]s | |||
== | ==US Brand Names== | ||
BACIIM<sup>®</sup> | |||
==FDA Package Insert== | |||
'''[[Bacitracin description|Description]]''' | |||
'''| [[Bacitracin clinical pharmacology|Clinical Pharmacology]]''' | |||
'''| [[Bacitracin microbiology|Microbiology]]''' | |||
'''| [[Bacitracin indications and usage|Indications and Usage]]''' | |||
'''| [[Bacitracin contraindications|Contraindications]]''' | |||
'''| [[Bacitracin warnings and precautions|Warnings and Precautions]]''' | |||
'''| [[Bacitracin adverse reactions|Adverse Reactions]]''' | |||
'''| [[Bacitracin overdosage|Overdosage]]''' | |||
'''| [[Bacitracin dosage and administration|Dosage and Administration]]''' | |||
'''| [[Bacitracin how supplied|How Supplied]]''' | |||
==Mechanism of Action== | |||
Bacitracin interferes with the dephosphorylation of the [[carbon|C]]<sub>55</sub>-isoprenyl pyrophosphate, a molecule which carries the building blocks of the [[peptidoglycan]] bacterial [[cell wall]] outside of the inner membrane [http://www.pnas.org/cgi/content/abstract/68/12/3223]. | |||
==References== | ==References== | ||
{{Reflist|2}} | |||
{{ | |||
[[ | [[Category:Antibiotics]] | ||
[[ | [[Category:Wikinfect]] | ||
Revision as of 15:37, 7 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohamed Moubarak, M.D. [2]
Overview
Bacitracin is a mixture of related cyclic polypeptides produced by organisms of the licheniformis group of Bacillus subtilis var Tracy. Its unique name derives from the fact that the bacillus producing it was first isolated in 1943 from a knee scrape from a girl named Margaret Tracy.[1] As a toxic and difficult-to-use antibiotic, bacitracin doesn't work well orally. However, it is very effective topically.
Bacitracin is synthesised via the so-called nonribosomal peptide synthetases (NRPSs), which means that ribosomes are not involved in its synthesis.
Category
US Brand Names
BACIIM®
FDA Package Insert
Description | Clinical Pharmacology | Microbiology | Indications and Usage | Contraindications | Warnings and Precautions | Adverse Reactions | Overdosage | Dosage and Administration | How Supplied
Mechanism of Action
Bacitracin interferes with the dephosphorylation of the C55-isoprenyl pyrophosphate, a molecule which carries the building blocks of the peptidoglycan bacterial cell wall outside of the inner membrane [3].